Panel Discussion: Understanding the Current Attitudes Towards Mandatory Vaccinations Before Dosing a Patient with Complement Inhibitors
Time: 4:00 pm
day: End of Day Two
Details:
- Re-evaluating the blanket vaccination requirements for complement inhibitors considering the emergence of novel, non-C5 complement inhibitors that show a lower infection risk compared to earlier C5 antibodies
- Discussing whether a blanket-approach remains justified, or whether a more nuance, risk stratified approach is warranted
- Navigating vaccination in acute vs chronic complement-mediated conditions, to mitigate infection risk without compromising rapid therapeutic intervention
